Tetraspanin CD151 is associated with laminin-binding integrins and controls tumor cell migration and invasion. By analyzing responses of breast cancer cells to various growth factors, we showed that depletion of CD151 specifically attenuates transforming growth factor β1 (TGFβ1)-induced scattering and proliferation of breast cancer cells in three-dimensional Matrigel. CD151-dependent cell scattering requires its association with either α3β1 or α6 integrins, but it is independent of the recruitment of CD151 to tetraspanin-enriched microdomains. We also found that CD151 regulates the compartmentalization of TGF-β type I receptor (TβRI/ALK-5) and specifically controls the TGFβ1-induced activation of p38. In contrast, signaling leading to activation of Smad2/3, c-Akt, and Erk1/2 proteins was comparable in CD151(+) and CD151(−) cells. Attenuation of TGFβ1-induced responses correlated with reduced retention in the lung vascular bed, inhibition of pneumocyte-induced scattering of breast cancer cells in three-dimensional Matrigel, and decrease in experimental metastasis to the lungs. These results identify CD151 as a positive regulator of TGFβ1-initiated signaling and highlight the important role played by this tetraspanin in TGFβ1-induced breast cancer metastasis.
Introduction
Tetraspanin protein CD151/Tspan24 is a member of a large family of four transmembrane domain proteins, which directly interacts with laminin-binding integrins (i.e., α3β1, α6β1/β4, and α7β1; refs. 1, 2). It affects their ligand-binding properties, thus regulating adhesion-dependent signaling and postadhesion events including cell migration (3) . In addition, it has been shown that CD151 regulates the internalization of the associated integrins, a process that is integral to cell motility (4) . Finally, we have recently reported that CD151 specifically affects glycosylation pattern of α3β1, and CD151-dependent differences in glycosylation of this integrin contribute to the modulatory activity of CD151 toward this integrin (5) .
In addition to this CD151 regulates activity of lamininbinding integrins through tetraspanin-enriched microdomains (TERM or TEM), molecular aggregates on the plasma membrane, which include other tetraspanins and cytoplasmic signaling proteins (3) . Association with CD151 is critical for the recruitment of laminin-binding integrins to TERM, where they can cooperate with other TERM-associated transmembrane proteins (6) .
Cooperation between integrins and receptors to various growth and chemotactic factors is well established and occurs at multiple levels (7, 8) . This involves cell type-specific association of various integrins with growth factor/ chemokine receptors (GF-/ChR), integrin-mediated control over ligand-induced activation of GF-/ChR, and adhesiondependent modulation of signaling pathways downstream of activated GF-/ChR. Integrin-associated transmembrane proteins including CD47, tetraspanins, and the L6-Ag family members can all function as mediators in communication between integrins and GF-/ChR (3, 9-11). We and others have previously described the association of tetraspanins with transmembrane receptors to growth factors including epidermal growth factor receptor (12, 13) , receptor to hepatocyte growth factor (c-Met; ref. 14) , and receptor for Steel factor (c-Kit; ref. 15) . Furthermore, it has been proposed that tetraspanin microdomains may represent a focal point in which signaling through integrins and receptors for growth/chemotactic factors can be coordinated (3) . Indeed, it has been shown that adhesion-dependent cellular responses triggered by activated c-Met are regulated by tetraspanins CD82 and CD151 (14, 16) . Likewise, CD81 and CD9 regulated adhesion-dependent proliferation in response to fibroblast growth factor (17) . In addition, tetraspanins may target growth factor receptors independent of their association with integrins (12, 14) , and this may involve tetraspanin-dependent changes in surface compartmentalization of the receptors (13, 18) .
Here, we found that depletion of CD151 attenuated the responses of breast cancer cells to transforming growth factor β1 (TGFβ1) in three-dimensional extracellular matrix (ECM). This correlated with specific changes in the TGFβ1-induced signaling leading to the activation of p38. Importantly, we found that attenuated responses to TGFβ1 correlated with decreased retention of CD151-depleted cells in the lungs, inhibition of tumor cell growth and scattering in coculture with lung epithelial cells, and, consequently, diminished metastatic burden of breast cancer cells.
Materials and Methods
Cells, antibodies, and reagents
low , MDA-MB-231/ α6β4 low , DCIS.com/CD151(+), and DCIS.com/CD151(−) cell lines were generated using appropriate short hairpin RNA lentiviral constructs with cells expressing low levels of the target proteins being selected after cell sorting (5, 19, 20) . MDA-MB-231/CD151rec, MDA-MB-231/CD151palm, and MDA-MB-231/CD151-QRD cell lines were established after the transfection of MDA-MB-231/CD151(−) cells with the wild-type and appropriate mutants of CD151 and subsequent selection CD151-expressing cells by cell sorting (5) . Cell lines expressing low levels of α6 integrins (MDA-MB-231/α6 low β1/ β4 and MDA-MB-231/α3β1 low α6 low β1/β4) were established by infecting of MDA-MB-231 and α3β1 low cells with pLVTHM-based lentivirus encoding short hairpin RNA that targets α6 integrin subunit (target sequence, 5′-GGUCGUGA-CAUGUGCUCAC-3′). To generate green fluorescent protein (GFP)-expressing cells, MDA-MB-231/CD151(+) and MDA-MB-231/CD151(−) were transduced with pLVTHM lentivirus (encoding GFP), which was produced in 293T cells using a standard protocol (20) . All MDA-MB-231 and 293T cells were grown in DMEM (Sigma) supplemented with 10% fetal bovine serum (FBS). HPL1D cells (21) were cultured in Ham F12 media with 5 μg/mL insulin, 5 μg/mL transferrin, 10 −7 mol/L hydrocortisone, 2 × 10 −7 mol/L thyronine, and 1%
of FBS. The mouse anti-CD151 monoclonal antibodies (mAb) used were 5C11 (22), 11B1G4 (provided by Dr. L. Ashman, University of Newcastle, Newcastle, Australia), and NCL-CD151 (Novocastra). Rabbit polyclonal antibodies against TGFβR1 were from Santa Cruz; mouse mAb against β-actin was from Sigma; and mouse mAb against β4 integrin subunit (3E1) was from Chemicon. Rabbit polyclonal antibodies to α3 and α6 integrin were generously provided by Dr. F. Watt (Cambridge Research Institute, Cambridge, UK) and Dr. A. Cress (Arizona Cancer Center, Tuscon, AZ). Mouse monoclonal to α3-(A3-IVA5), α6-(A6-ELE), and β1-(TS2/16) integrin subunit were previously described (23) (24) (25) . The rest of the antibodies used in this study were purchased from Cell Signaling Technology. All growth factors were purchased from PeproTech. SB431542 was from Calbiochem.
Culturing cells in three-dimensional Matrigel
Cell culturing in three-dimensional Matrigel was previously described (20) . In some experiments, cells were cultured in endothelial basal medium (Promocell), which was supplemented with 2% FBS and various growth factors/chemokines (at 10 ng/mL); growth medium was replaced every third day. To evaluate cell proliferation in three-dimensional Matrigel, AlamarBlue (Invitrogen) was added at different time points to the growth media and cells were further incubated for 4 hours at 37°C. Fluorescence of the samples was measured using the Fluoroskan plate reader. In cell coculture experiments, HPL1D cells were grown in 48-well plates until they reached 80% confluency: MDA-MB-231 cells suspended in Matrigel (8 × 10 3 /200 μL) were subsequently overlaid and cultured for 7 to 10 days with growth media (DMEM/10%FCS) being replaced every third day. In some experiments, GFP-expressing MDA-MB-231 cells were premixed with HPL1D cells at the ratio 1:100 and incubated for 30 to 60 minutes on a slowly rocking platform to induce the formation of cell aggregates. Aggregates were carefully suspended in Matrigel and cultured for 7 to 10 days. For all three-dimensional culture experiments, representative pictures were taken every 2 to 3 days using the Nikon Eclipse TS100 microscope.
Analysis of TGFβ1-induced signaling
Cells spread on Matrigel-coated (10 μg/mL) culture plates were serum starved overnight and subsequently stimulated with 10 ng/mL TGFβ1 for different length of time. Cells were lysed in the ice-cold Laemmli buffer supplemented with 2 mmol/L phenylmethylsulfonyl fluoride, 10 μg/mL aprotinin, 10 μg/mL leupeptin, 100 mmol/L Na3VO4, 10 mmol/L NaF, and 10 mmol/L Na3P4O7. Proteins separated by SDS-PAGE were transferred onto nitrocellulose membrane and probed with various antibodies using a standard protocol.
Fractionation in sucrose gradient
Fractionation of cellular lysates in the gradient of sucrose was carried out as previously described (13, 18) . In brief, cells were homogenized in 100 mmol/L Na 2 CO 3 (pH 11.0) by passing through a 25G hypodermic needle, and the lysates were subsequently sonicated (4 × 20 s bursts, 1-min interval, power 20). The lysates were mixed with two volumes of 2 mol/L sucrose solution and overlaid with two sucrose solutions (35% and 5%). Samples were centrifuged at 100,000 g for 16 to 18 hours at 4°C in a Beckman SW60 rotor, and 10 equal volume fractions were collected from the top of gradient. The pellet was suspended in 200 μL of the lysis buffer. Equal amounts of each fraction were mixed with 4× Laemmli loading buffer, and the proteins were resolved by SDS-PAGE. Fractional distribution of proteins was subsequently analyzed by Western blotting.
Flow cytometry analysis
Cells were detached with enzyme-free cell dissociation buffer (Life Technologies) and kept for 1 hour on ice with saturating concentrations of appropriate mouse monoclonal antibodies. Staining was visualized using phycoerythrin-conjugated goat anti-mouse IgG antibodies, and samples were analyzed with COULTER Epics XL.
Metastasis experiments
All experiments were performed in accordance with institutional and national animal research guidelines. Cells were injected i.v. into the lateral tail vein of 4-to 5-week-old athymic mice to evaluate lung colonization. Mice were injected with 5 × 10 5 cells/150 μL PBS/mouse. Six to 10 animals per group were used in the experiments. The experiments were terminated 8 weeks postinjection (or earlier if mice with adverse symptoms were observed). At termination, the lungs were removed and fixed in 10% buffered formalin and processed for histologic and immunohistochemical analyses.
Histology and morphometry
Paraffin sections of formalin-fixed lungs were processed routinely for histology. The sections stained with H&E were analyzed, and images were captured using the Nikon E400 DS-U2/L2 software (Japan). For quantitative analysis, four sections at the distance of 200 μm on either side of the hilum were cut and immunostained for vimentin (DAKO) using a standard avidin-biotin-peroxidase complex method. Metastatic foci were counted in two low-power fields (4×) at each level, and their area was quantified using the AxioVision LE software (Zeiss). The numbers represent the average from eight counts per measurements. The mean ± SEM was calculated, and statistical analyses were carried out by the unpaired t test using a GraphPad Prism 3.2 program (GraphPad Software).
Analysis of tumor cell trafficking in vivo using intravital microscopy
Male C57BL/6 mice were anaesthetized with ketamine hydrochloride (100 mg/kg Vetalar; Amersham Biosciences and Upjohn Ltd.) and xylazine hydrochloride (10 mg/kg; Millpledge Pharmaceuticals). Animals subsequently underwent carotid artery cannulation to allow administration of cells fluorescently labeled with BCECF-AM (PPL 40/2749). Following laparotomy, the left hepatic lobe was exteriorized and visualized intravitally using an inverted fluorescent microscope (Olympus). MDA-MB-231/CD151(+) or MDA-MB-231/CD151 (−) (1 × 10 6 ) cells were administered in a 100-μL bolus through the carotid artery. Seven fields of view containing a postsinusoidal venule and surrounding sinusoidal capillaries were analyzed 1 hour postinjection of cells. Lung tissue was isolated from sacrificed mice at the end of the intravital experiments. Tissue was washed in 0.9% saline and also analyzed on the inverted fluorescent microscope. Ten fields of view were selected in a set pattern, and adherent cells were counted. The average from these 10 fields was obtained from each of the five separate experiments.
Results

Depletion of CD151 affects the responses of breast cancer cells to TGFβ1
We have analyzed whether the absence of CD151 can affect responses of breast cancer cells to various growth factors and chemokines. Initially, we used MDA-MB-231/CD151(+) and MDA-MB-231/CD151(−) cells, and assessed the growth of these cells in three-dimensional Matrigel. In agreement with the previous studies, we found that depletion of CD151 did not affect surface expression of predominant integrins in MDA-MB-231 cells ( Supplementary Fig. S1 ). Ten growth/chemotactic factors were analyzed in these experiments including PDGF-BB, HB-EGF, EGF, bFGF, SDF-1, TGFα, HGF, TGFβ1, IGF-I, and IL-1. Under the control conditions (i.e., in the absence of additional growth factors), both MDA-MB-231/CD151(+) and MDA-MB-231/CD151(−) cells formed compact round aggregates (Fig. 1A, top) . The morphologic appearance of colonies was not affected when cells were cultured in the presence of HGF, IL-1, EGF, IGF-I, PDGF-BB, SDF1, HB-EGF, and TGFα (Supplementary Fig. S2 and results are not shown). Tight intercellular interactions within aggregates were looser in the presence of bFGF, but we observed no apparent difference between the CD151(+) and CD151(−) cells ( Supplementary Fig. S2 ). By contrast, the CD151-dependent differential response was seen when cells were grown in the presence of TGFβ1. While <20% of CD151-positive aggregates retained compact morphology, the majority of colonies appeared as aggregates of loosely associated cells, some of which developed characteristic thin protrusions (thereafter, we referred to this type of colony as having a "scattered" phenotype; Fig. 1A , bottom left). Short protrusions were first observed 4 days after cells were seeded in Matrigel, and they gradually became more prominent after 8 days in three-dimensional culture (Fig. 1B) . In contrast to CD151-positive cells, ∼80% of MDA-MB-231/ CD151(−) colonies remained compact and had smooth contours during the time course of the experiments (Fig. 1A , bottom right, and C). Although there was no obvious difference between CD151-positive and CD151-negative cells in the number of colonies formed in the presence of TGFβ1, the proliferative rate of MDA-MB-231/CD151(−) cells appeared to be consistently lower (Fig. 1D) . Similarly, TGFβ1-induced proliferation of another breast cancer cell line (DCIS.com) was also attenuated after depletion of CD151 ( Supplementary  Fig. S3 ). Importantly, the effect of CD151 depletion on TGFβ1-induced signaling was specific as knockdown of tetraspanin CD81 did not change responses of MDA-MB-231 cells ( Supplementary Fig. S4 ). These data showed that CD151 specifically regulates TGFβ1-induced responses of breast cancer cells in three-dimensional Matrigel.
The role of CD151-associated integrins and tetraspanin microdomains in regulating cellular responses to TGFβ1
We and others have previously reported that in MDA-MB-231 cells, the function of CD151 is closely linked to lamininbinding integrins (i.e., α3β1, α6β1, and α6β4; refs. 5, 20, 26) . To examine the involvement of these integrins in CD151-dependent scattering induced by TGFβ1, we initially examined the responses of MDA-MB-231/CD151-QRD cells (5) . These cells were derivative of MDA-MB-231/CD151(−) line, and they expressed the mutant of CD151 deficient in its ability to form complexes with integrins (5). As illustrated in Fig. 2 , the response of MDA-MB-231/CD151-QRD cells was comparable with that of the CD151-negative cells with ∼90% of all colonies remaining compact in the presence of TGFβ1. By contrast, the response to TGFβ1 was restored when MDA-MB-231/CD151(−) cells were reconstituted with the wild-type CD151 ( Fig. 2A and B) . Flow cytometry experiments have shown that CD151-QRD and CD151wt proteins expressed at the comparable levels on the surface of reconstituted MDA-MB-231 cells (Supplementary Table S1 ). We next investigated which of the laminin-binding integrins contribute to CD151-dependent responses of MDA-MB-231 cells to TGFβ1. To this end, we have generated two new cell lines: MDA-MB-231/α6β1/β4 low , deficient in expression of both α6 integrins (i.e., α6β1 and α6β4), and MDA-MB-231/α3β1 low α6 β1/β4 low , deficient in expression of all laminin-binding integrins (Supplementary Fig.  S1A ). In these experiments, we also used α3β1-deficient cells (MDA-MB-231/α3β1 low ; ref. 20) . Surprisingly, both MDA-MB-231/α3β1 low and MDA-MB-231/α6β1/β4 low cells were able to form colonies with characteristic scattered appearance, and only deficiency in all CD151-associated integrins completely abolished responses to TGFβ1 (Supplementary Fig. S5; Fig. 2C ). These results confirmed that the modulatory activity of CD151 requires its association with integrins and suggested functional redundancy of various CD151-integrin complexes in TGFβ1-induced scattering. Palmitoylation-dependent recruitment of the proteins to tetraspanin-enriched microdomains is critical for many of the tetraspanin activities (27) . To investigate whether palmitoylation of CD151 is necessary for TGFβ1-induced responses, we analyzed the behavior of MDA-MB-231/ CD151palm(−) cells. As illustrated in Fig. 2D , expression of palmitoylation-deficient CD151 in MDA-MB-231/CD151 (−) fully restored the ability of the cells to form scattered colonies in the presence of TGFβ1. These results indicated that the association with other tetraspanins (and recruitment to tetraspanin microdomains) was not essential for CD151-dependent cellular responses to this cytokine. The effect of CD151 depletion on TGFβ1-induced signaling Pleiotropic effects of TGFβ1 on cell behavior is mediated by Smad proteins, which function as transcriptional modulators, and through activation of several Smad-independent signaling pathways involving P13-K, Erk1/2, and p38 kinases (28) . To analyze how depletion of CD151 affects TGFβ1-induced signaling, we assessed phosphorylation of various TGFβ1 targets in cells plated on Matrigel under serum-free conditions and subsequently stimulated with the cytokine for various time intervals. As expected, incubation with TGFβ1 resulted in the phosphorylation of Smad2 and Smad3: the phosphorylation levels of the proteins peaked at 1 hour after the stimulation and then decreased to undetectable levels by 12 hours (Fig. 3A and B) . We observed no difference between CD151-positive and CD151-negative cells in the kinetics and degree of phosphorylation of Smad2/3 proteins in these experiments ( Fig. 3A and B) . Thus, it seemed that CD151 does not influence Smad-dependent signaling pathway. Similarly, phosphorylation levels of Erk1/2 and c-Akt were comparable at all analyzed time points (data not shown; Fig. 3A and B) . By contrast, there was a consistent difference in TGFβ1-induced phosphorylation of p38. In MDA-MB-231/CD151(+) cells, after the initial sharp increase (∼4-fold increase), the level of phospho-p38 has returned to its basal level (i.e., 0 time point) by 48 hours. On the other hand, the degree of TGFβ1-induced phosphorylation of p38 in CD151-negative MDA-MB-231 cells was significantly lower when compared with nonstimulated cells, with maximal ∼1.5-fold increase by 1 hour (Fig. 3A and C) . Furthermore, p38 phosphorylation was sustained at almost the same level for up to 48 hours. A specific CD151-dependent effect on TGFβ1-induced phosphorylation of p38 was also observed in DCIS.com cells (Supplementary Fig. S6 ). These results showed that CD151 deficiency resulted in specific alterations in TGFβ1-induced signaling. It has been recently reported that TGFβ1-induced activation of p38 was influenced by cholesterol-dependent redistribution of TGF-β type I receptor (TβRI/ALK-5) on the plasma membrane (29) . Fractionation in sucrose gradient was used to examine whether the effect of CD151 on p38 activation also involves changes in the membrane compartmentalization of TβRI/ALK-5. Although the major pool of TβRI/ALK-5 molecules was found in the heavy fractions of sucrose gradient, a significant proportion of the receptor was floating in the light fractions (Fig. 3D) . Importantly, we have consistently observed (three independent experiments) that depletion of CD151 in MDA-MB-231 cells resulted in the decrease in the proportion of TβRI/ALK-5 in the light fraction of the gradient. Control experiments have shown that the total cellular levels of TβRI/ALK-5 were comparable in CD151(+) and CD151(−) cells ( Supplementary  Fig. S7 ). By contrast, fractional distribution of CD151 and the associated integrins was different with most of the signal detected in the fractions 3 to 6 (Fig. 3D) . Furthermore, depletion of CD151 resulted in the redistribution of α3β1 in sucrose gradient fractions. In additional experiments, we found no evidence for the interaction between CD151 and TβRI/ALK-5 (data not shown).
Depletion of CD151 attenuates pulmonary metastasis of breast cancer cells
It has been reported that TGFβ1 plays a critical role in pulmonary metastasis of MDA-MB-231 (30) . Thus, we used to examine whether attenuated responses to TGFβ1 in MDA-MB-231/CD151(−) would correlate with decreased metastatic potential of these cells. We found that although both CD151-positive and CD151-negative MDA-MB-231 cells gave rise to multiple metastatic lesions in the lungs (Supplementary Fig. S8 ), the area occupied by the lesions and their number were decreased in the absence of CD151 (Fig. 4A and B) . In animals implanted with CD151-positive cells an average relative area of all lesions in all examined lung fields was ∼1.65%. In comparison, this parameter was 0.46% for mice injected with MDA-MB-231/CD151(−) cells. These results indicate that CD151 is involved in establishing and growth of metastatic lesions in the lungs.
Depletion of CD151 attenuates the immediate trafficking of breast cancer cells to the lungs in vivo
Although the lung metastasis model allows assessment of the metastatic process as a whole, it does not discriminate between different steps, which might be affected by CD151. As a starting point toward uncovering the involvement of CD151 in metastasis, we analyzed whether CD151 regulates the immediate recruitment of breast cancer cells to the vasculature of the lungs. MDA-MB-231/CD151(+) and MDA-MB-231/CD151(−) cells were injected into the mouse vascular system through the carotid artery, and their immediate recruitment to the lung and liver microcirculation was monitored by intravital microscopy. The liver was examined in addition to the lungs to determine whether CD151 is involved in site-specific recruitment of breast cancer cells. A significant reduction in lung recruitment of CD151-negative MDA-MB-231 cells was observed ( Fig. 5A and B) . On the other hand, hepatic recruitment of CD151-positive and CD151-negative MDA-MB-231 did not differ during the 1-hour duration of the experiment (Fig. 5B) .
Depletion of CD151 attenuates responses of breast cancer cells to lung epithelial cells
To explore further the involvement of CD151 in pulmonary metastasis, we compared responses of CD151-positive and CD151-negative MDA-MB-231 to lung epithelial cells. HPL1D is a human immortalized small airway epithelial cell line with cells retaining some of the characteristics of type II pneumocytes (21) . In the initial experiments, we analyzed growth of MDA-MB-231 cells in threedimensional Matrigel placed above the monolayer of HPL1D pneumocytes. Under these conditions, most of the MDA-MB-231/CD151(+) cells developed characteristic scattered aggregates (Fig. 6A, top) . These colonies morphologically resemble those induced by TGFβ1 (shown in Fig. 1 ). In contrast, most of the CD151-negative cells were nonresponsive to the presence of pneumocytes and formed compact aggregates with smooth contours (Fig. 6A,  bottom) . The CD151-dependent differential responses to pneumocytes were also observed when we cultured preaggregated clusters of HPL1D and MDA-MB-231 cells in three-dimensional Matrigel (Supplementary Fig. S9 ). To examine whether TGFβ1 is involved in pneumocyte-induced scattering, we performed the coculturing experiment in the presence of SB431542, a specific inhibitor for TβRI/ALK5. As shown in Fig. 6B , the presence of SB431542 completely abrogated the modulatory effect of pneumocytes on MDA-MB-231 cells. Thus, we concluded that in the absence of CD151, the responses of breast cancer cells to pneumocyte-derived TGFβ1 are suppressed, and this is likely to be an important contributory factor for the attenuated metastatic properties of CD151-deficient cells. 
Discussion
Cytokines of TGFβ superfamily are implicated in a variety of normal and pathologic phenomena (31) . Here, we identified tetraspanin CD151 as a novel regulator of TGFβ-induced signaling and showed that attenuated cellular responses to TGFβ correlated with reduced metastastic potential of breast cancer cells.
Our results indicate that the modulatory activity of CD151 toward TGFβ1-induced cellular responses is dependent on its association with integrins and correlates with the redistribution of TβRI/ALK5 on the plasma membrane. Notably, this does not require recruitment of CD151 to tetraspanin microdomains, critical structural and functional units on the cell surface (3). The fact that TβRI/ALK5 and CD151 do not interact with one another suggests that the mode of regulation involves more general CD151-dependent changes on the plasma membrane, which may, as a result, affect the distribution of TGFβ receptors. In this regard, not only does CD151 directly bind cholesterol (32) , but tetraspanins may also control the expression level and compartmentalization of gangliosides (13) , glycosphingolipids that represent the major structural block of various types of membrane microdomains (33) . It is also feasible that in addition to its regulatory role in surface distribution of TβRI/ALK5, CD151 (in complex with laminin-binding integrins) can alter signaling downstream of the activated receptor. Although this selective mode of action was not previously associated with tetraspanins, it has been extensively documented for various integrin-growth factor receptor pairs (7, 9) .
We found that TGFβ1-induced scattering (MDA-MB-231 cells) and proliferation (MDA-MB-231 and DCIS.com) of CD151-deficient cells in three-dimensional Matrigel were dramatically reduced when compared with the control, CD151-positive cells. Attenuated responses to TGFβ1 in CD151-depleted cells correlated with differences in TGFβ-induced activation of p38. On the other hand, signaling pathways leading to activation of Erk1/2, c-Akt, and phosphorylation of Smad2/3 were not affected in CD151(−) cells. Although CD151-dependent variations in the activation of p38 may not be the only factor that underlies differential responses to TGFβ1, they can certainly contribute to CD151-dependent phenotypes in three-dimensional Matrigel. Indeed, a proproliferative function of p38 in various types of cancer cells is well established (34) . Although there seems to be no study that specifically addressed the involvement of p38 in scattering of cells in three-dimensional ECM, activation of this enzyme can certainly contribute to this phenomenon. In this regard, it has been recently reported that TGFβ-induced transcription of matrix metalloproteinase 2, an enzyme which plays an important role in pericellular proteolysis of ECM by mammary epithelial cells, is controlled by ATF2, a well-established target for p38 (35) . Furthermore, activation of p38 was shown to be critical for TGFβ1-induced activation MT1-MMP/MMP-14 (36), a key enzyme for invasive migration within three-dimensional ECM (37) . p38 is also known to regulate expression levels and turnover of various cell-cell adhesion proteins and therefore may further contribute to the development of "scattering phenotype" in response to TGFβ1 treatment (38) (39) (40) . In spite of this, it seems that by itself, modulation of p38 activity in response to TGFβ1 is not sufficient to induce cell scattering in three-dimensional ECM. Indeed, although TGFβ1 could potently induce the activation of p38 in DCIS.com/CD151(+), the colonies formed by the cells in three-dimensional Matrigel in the presence of this growth factor did not exhibit typical scattering phenotype (i.e., loosening cell-cell contacts, developing characteristic invasive protrusions). These data strongly suggest that TGFβ1-induced activation of p38 and its contribution to scattering in three-dimensional ECM relies on other signaling pathways that are either absent or not fully functional in DCIS.com cells.
Although as a whole, cellular interactions with LN-111 in Matrigel matrix are essential, the function of each of the laminin-binding integrins in developing of TGFβ1-induced scattering phenotype by MDA-MB-231 cells seems to be redundant. Indeed, only in α3/α6-deficient MDA-MB-231 cells did we observe complete abrogation of the scattering response to TGFβ1. The fact that MDA-MB-231/α6β1/ β4 low cells are able to respond to TGFβ1 is particularly intriguing and raises the question of how α3β1, the only remaining laminin-binding integrin in these cells, supports scattering behavior. It is now well established that whereas α6β1 and α6β4 integrins represent principal receptors for LN-111 and can deliver biomechanical signals necessary for scattering, α3β1 does not bind this substrate (41) and, therefore, should utilize an alternative mode of action. One possibility is that whereas other adhesion receptors (and ECM components of Matrigel) in α6-deficient MDA-MB-231 cells provide a "mechanical" support for scattering, the CD151-α3β1 complex regulates the development of cell protrusions and movement in three-dimensional ECM in an adhesion-independent manner. Alternatively, in the absence of α6 integrins and upon treatment with TGFβ1, α3β1 controls scattering by mediating adhesion to nonlaminin components of Matrigel (42) . Further experiments will be necessary to address this question.
Deficiency in responses to TGFβ1 correlated with impaired metastatic potential of CD151-depleted MDA-MB-231 cells. Our observation is complementary to a recent report showing that signaling induced by TGFβ through the Smad-dependent pathway(s) is critical for recruitment to and retention of breast cancer cells in the lungs (30) . Interestingly though, we found that in the absence of CD151, TGFβ1-induced phosphorylation of Smad proteins was not affected. Therefore, it is unlikely that the mechanisms underlying the prometastatic activity of CD151 involve the induction of angiopoietin-like 4 (ANGPTL4) as shown by Padua and Massague (30) . In fact, our data suggest that by potentiating cellular responses to TGFβ1 CD151 promotes the metastatic process at two levels: it enhances cell proliferation and facilitates local invasiveness (hence, increased size and number of metastatic lung lesions formed by CD151-positive cells).
Our results indicate that breast cancer cells, which express CD151, are more readily retained in the lung microvascular bed. These results revealed yet an additional metastasis promoting function for CD151. Although relatively small CD151-dependent increase in the numbers of tumor cells in the lung microvascular bed was highly reproducible and specific: indeed, we found that recruitment of cells in the liver vasculature was independent of CD151 expression. These data further emphasize differences in the molecular mechanisms underlying organ-specific recruitment during the metastatic process. A recent report by Zijlstra and colleagues (43) has shown that CD151 may contribute to metastasis by regulating intravasation of the cells into the vascular system at the primary tumor site. In their experiments, metastasis-suppressing anti-CD151 mAb did not affect tumor cell arrest in the lungs or alter growth of secondary colonies. Although these "discrepancies" can be simply explained by differences in the cell models used, it is also likely that the antibodyinduced inhibitory pathways may be distinct from the intrinsic cellular mechanisms that control the metastatic potential of tumor cells.
In conclusion, we have identified tetraspanin CD151 as a new modulator of TGFβ1-induced signaling. Although in this study, we have specifically focused on TGFβ-induced responses of breast cancer cells, it is likely that a newly established functional link between CD151 and TGFβ1 may be in operation during the metastatic progression in many other cancers in which elevated expression of the tetraspanin will sensitize cancer cells to TGFβ cytokines. Thus, future experiments toward unraveling the molecular details of the CD151-TGFβ1 communication will be necessary to understand TGFβ-dependent cancerous progression.
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